Compounds > telmisartan
Page last updated: 2024-08-24

telmisartan and Injury, Myocardial Reperfusion

telmisartan has been researched along with Injury, Myocardial Reperfusion in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Arya, DS; Bhatia, J; Garg, S; Kaur, P; Khan, SI; Kumar, M; Malhotra, RK; Nag, TC; Ray, R; Sharma, MK1
D'Amico, M; Ferraro, B; Gulotta, E; Messina, A; Nicoletti, GF; Panarese, I; Pieretti, G; Trotta, MC1
Li, XS; Wen, H; Zeng, XC1
Chaudagar, KK; Mehta, AA1
Arya, DS; Bharti, S; Bhatia, J; Goyal, SN; Nag, TC; Ray, R1
Capuano, A; D'Amico, M; Di Filippo, C; Donniacuo, M; Ferraraccio, F; Rinaldi, B; Rossi, F; Sodano, L1

Other Studies

6 other study(ies) available for telmisartan and Injury, Myocardial Reperfusion

ArticleYear
Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:7

    Topics: Animals; Benzimidazoles; Cardiotonic Agents; Disease Models, Animal; Male; MAP Kinase Signaling System; Myocardial Reperfusion Injury; Myocardium; Oxadiazoles; Rats; Rats, Wistar; Telmisartan

2021
Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:10

    Topics: Animals; Cell Hypoxia; Cell Line; Cell Survival; Connexin 43; KCNQ1 Potassium Channel; Male; MicroRNAs; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Telmisartan

2019
Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.
    BMC cardiovascular disorders, 2013, Jun-05, Volume: 13

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Cardiotonic Agents; Male; Myocardial Reperfusion Injury; PPAR gamma; Rabbits; Random Allocation; Signal Transduction; Telmisartan

2013
Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Endothelial Cells; Heart; Male; Myocardial Reperfusion Injury; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; PPAR gamma; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Telmisartan; Vascular Endothelial Growth Factor A

2014
Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
    Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Myocardial Reperfusion Injury; Myocardium; PPAR gamma; Rats; Telmisartan

2011
Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:4

    Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cardiotonic Agents; Disease Models, Animal; Heart; Immunohistochemistry; Metabolic Syndrome; Myocardial Reperfusion Injury; NF-kappa B; PPAR gamma; Rats; Rats, Zucker; Telmisartan; Troponin I; Tumor Necrosis Factor-alpha

2012